Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide
September 27, 2014 10:15 ET
|
Endocyte, Inc.
- Data Presented Today as Late-Breaker at European Society for Medical Oncology (ESMO) 2014 Congress in Madrid -
- Interim Update of Overall Survival Analysis Shows 30 Percent Reduction of Risk of...
Canon Solutions America's Paper Partners Featured at Graph Expo
September 27, 2014 09:01 ET
|
Canon Solutions America
MELVILLE, N.Y., Sept. 27, 2014 (GLOBE NEWSWIRE) -- Canon Solutions America, Inc., a subsidiary of Canon U.S.A., Inc., will showcase its unique inkjet printing capabilities at the Canon U.S.A. booth,...
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Rocket Fuel Inc. to Contact Brower Piven Before the November 3, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- FUEL
September 27, 2014 08:00 ET
|
Brower Piven, A Professional Corporation
STEVENSON, Md., Sept. 27, 2014 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the...
Patients lived average of 18 months without cancer progressing when taking Novartis' Zykadia(TM) as their first ALK inhibitor for ALK+ NSCLC
September 27, 2014 06:45 ET
|
Novartis Pharma AG
Longest median progression-free survival (PFS) ever reported in this ALK+ non-small cell lung cancer patient population, most who received prior chemotherapy[1] Zykadia (ceritinib) achieved...
HB Grandi hf. Flöggun LSR - Dagsetning viðskipta 26. september 2014
September 27, 2014 05:37 ET
|
Brim hf.
Sjá viðhengi...
Novartis drug Afinitor is first treatment for advanced pancreatic NET to provide overall survival of more than 3.5 years in Phase III trial
September 27, 2014 05:00 ET
|
Novartis Pharma AG
Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement[1] Pancreatic NET (pNET) affects...
Eccentry Holidays Sunny Isles Provides Families with Great Time Saving Disney World Tips for the Fall
September 27, 2014 03:05 ET
|
Eccentry Holidays Sunny Isles
MIAMI, Fla., Sept. 27, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Millions of families choose to visit Walt Disney World in Orlando, Florida, every year for their annual family vacation. Eccentry Holidays...
Child Enrichment Centre, Scholar Base, Today Announces its Annual Open Day Featuring Performances from Students and an Exclusive Promotional Offer for New Registrations
September 27, 2014 03:03 ET
|
Scholar Base
KUALA LUMPUR, Malaysia, Sept. 27, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Child development centre, Scholar Base, today announces its annual Open Day, raising public awareness for the centre's programmes...
EQUITY ALERT: The Rosen Law Firm Reminds IRadimed Corporation Investors of Important Deadline in Class Action Filed by Firm -- IRMD
September 26, 2014 23:22 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 26, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of IRadimed Corporation (Nasdaq:IRMD) common stock between July 15, 2014 and September 2, 2014, of the important...
EQUITY ALERT: Rosen Law Firm Reminds Marrone Bio Innovations, Inc. Investors of Important Class Action Deadline - MBII
September 26, 2014 23:11 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 26, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds purchasers of Marrone Bio Innovations, Inc. securities (Nasdaq:MBII) between March 7, 2014 and September 2, 2014, of the...